FindTrial
Sign In

Establishing a standard system of diagnosis and treatment for atrial fibrillation and evaluating the preventive efficacy of warfarin on infarction

Establishing a standard system of diagnosis and treatment for atrial fibrillation and evaluating the preventive efficacy of warfarin on infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-PON-15007605
Enrollment
Unknown
Registered
2015-12-16
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

experimental group:warfarin+education
control:none

Sponsors

Yangzhou 1st People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. more than 18 years old; 2. subjects with AF; 3. sign a consent form and patients receive warfarin.

Exclusion criteria

Exclusion criteria: 1. patients with cerebral hemorrhage or SAH; 2. patients with non- cardiogenic stroke; 3. severe hepatic and renal dysfunction; 4. patients with mental illness.

Design outcomes

Primary

MeasureTime frame
complaince;—

Secondary

MeasureTime frame
complication;—

Countries

China

Contacts

Public ContactXinjiang Zhang
lzhangxinjiang@sina.com+86 15852880352

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026